PZ Cussons (LON:PZC – Get Free Report) announced its quarterly earnings data on Tuesday. The company reported GBX 3.89 ($0.05) earnings per share for the quarter, Digital Look Earnings reports. PZ Cussons had a negative return on equity of 21.85% and a negative net margin of 10.80%.
PZ Cussons Price Performance
LON:PZC opened at GBX 86.40 ($1.08) on Thursday. The stock has a 50 day moving average price of GBX 81.03 and a 200 day moving average price of GBX 88.72. The stock has a market cap of £362.44 million, a PE ratio of -617.14, a P/E/G ratio of 1.13 and a beta of 0.26. The company has a debt-to-equity ratio of 75.98, a quick ratio of 1.36 and a current ratio of 1.18. PZ Cussons has a one year low of GBX 74.50 ($0.93) and a one year high of GBX 118.20 ($1.47).
Analyst Ratings Changes
Separately, Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a GBX 120 ($1.49) target price on shares of PZ Cussons in a research report on Friday, November 22nd.
PZ Cussons Company Profile
PZ Cussons plc manufactures, distributes, markets, and sells baby, beauty, and hygiene products in Europe, the Americas, the Asia Pacific, and Africa. The company offers toiletries, pharmaceuticals, electrical goods, edible oils, fats and spreads, nutritional products, shampoos, body washes, toothpastes, toothbrushes, skin and hair care products, food pouches, cereals, snacks, flavors, and fragrances; beauty soaps, lotions, wipes, creams, shower gels, foam-bursts, bar soaps, deodorants, bath infusions, handwashes, and conditioners; ointments; dishwashing liquids, dishwasher tablets, dishwasher gels, dishwasher capsules, rinse aids, liquid detergents, laundry soaps, and laundry solutions; and cooking and vegetable oils.
Recommended Stories
- Five stocks we like better than PZ Cussons
- Growth Stocks: What They Are, What They Are Not
- PayPal: Time to Strike With Shares Down Double Digits?
- Overbought Stocks Explained: Should You Trade Them?
- Lattice Semiconductor’s Market Reset Is Over: The Rebound Begins
- Investing In Preferred Stock vs. Common Stock
- Will Eli Lilly Stock Keep Climbing? Q2 Trial Results Are Crucial
Receive News & Ratings for PZ Cussons Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PZ Cussons and related companies with MarketBeat.com's FREE daily email newsletter.